Efficacy and safety of teneligliptin in combination with pioglitazone in Japanese patients with type 2 diabetes mellitus
about
Teneligliptin in management of type 2 diabetes mellitusCardiovascular Safety of Dipeptidyl-Peptidase IV Inhibitors: A Meta-Analysis of Placebo-Controlled Randomized Trials.GLP-1(28-36)amide, the Glucagon-like peptide-1 metabolite: friend, foe, or pharmacological folly?Teneligliptin, a Dipeptidyl Peptidase-4 Inhibitor, Improves Early-Phase Insulin Secretion in Drug-Naïve Patients with Type 2 Diabetes.Teneligliptin: a review in type 2 diabetes.Network meta-analysis of liraglutide versus dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes in Japanese patients.Safety and efficacy of teneligliptin in Japanese patients with type 2 diabetes mellitus: a pooled analysis of two Phase III clinical studies.Efficacy and safety of teneligliptin.Long-term safety and efficacy of canagliflozin as add-on therapy to teneligliptin in Japanese patients with type 2 diabetes.Practical strategies for improving outcomes in T2DM: The potential role of pioglitazone and DPP4 inhibitors.Efficacy and safety of teneligliptin add-on to insulin monotherapy in Japanese patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled trial with an open-label period.Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, placebo-controlled, parallel-group comparative study.Efficacy and Safety of Teneligliptin 40 mg in Type 2 Diabetes: A Pooled Analysis of Two Phase III Clinical Studies.Efficacy and Safety of Teneligliptin in Indian Patients with Inadequately Controlled Type 2 Diabetes Mellitus: A Randomized, Double-blind Study.Efficacy and safety of teneligliptin, a dipeptidyl peptidase-4 inhibitor, combined with metformin in Korean patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled phase III trial.Safety and Efficacy of Teneligliptin in Patients with Type 2 Diabetes Mellitus and Impaired Renal Function: Interim Report from Post-marketing Surveillance.Efficacy and Safety of Teneligliptin in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Relationship of Eating Patterns and Metabolic Parameters, and Teneligliptin Treatment: Interim Results from Post-marketing Surveillance in Japanese Type 2 Diabetes Patients.
P2860
Q26738356-1663B164-E17D-4765-BF8E-17792D9595A2Q30240823-D417F413-DB94-4AD6-A430-E020168BA278Q33734024-D8871529-B9B1-4999-BCF8-3A7046F4CD21Q36031120-3614875D-8F54-4251-87B7-48D3A970D92BQ38609598-E9CB0FAE-45B9-4FB9-BAA1-3CC515BC3BCBQ38716033-B36D908C-702C-461B-B7B1-EEDCBFF89A93Q41090670-BC04497A-5BA0-4707-8274-7EEC5C467FD3Q42330154-9879BA9B-B0AC-4383-AF13-52A07B4B5B00Q47148933-62AA5D14-426D-4E40-8916-B509385E8A71Q47697775-FFE5AC37-CFE7-4C31-92E8-636851BFDC7AQ48031376-2FCEB0A7-5765-4B01-81C6-B45016837FEFQ48274765-3D4265DC-A9B2-44F3-8C29-43AAA2F78CCFQ50050575-B8862F9C-7C24-429D-852A-C56F3F67B35FQ51245374-A3242197-3CCD-438E-A754-98DC832550F5Q51311444-C9C39F4E-8C0F-4F8B-8160-FDDE77FF8284Q52594764-E8BD99C3-0296-4657-BF5A-1D2F1FBD59E0Q55340870-EEEBB0CD-8D77-4693-9C2C-38A1340F7871Q55401867-64CA4BA2-3140-4B0D-AA5E-4F1DB2922100
P2860
Efficacy and safety of teneligliptin in combination with pioglitazone in Japanese patients with type 2 diabetes mellitus
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Efficacy and safety of tenelig ...... with type 2 diabetes mellitus
@ast
Efficacy and safety of tenelig ...... with type 2 diabetes mellitus
@en
type
label
Efficacy and safety of tenelig ...... with type 2 diabetes mellitus
@ast
Efficacy and safety of tenelig ...... with type 2 diabetes mellitus
@en
prefLabel
Efficacy and safety of tenelig ...... with type 2 diabetes mellitus
@ast
Efficacy and safety of tenelig ...... with type 2 diabetes mellitus
@en
P2860
P356
P1476
Efficacy and safety of tenelig ...... with type 2 diabetes mellitus
@en
P2093
Kazuoki Kondo
Takashi Kadowaki
P2860
P304
P356
10.1111/JDI.12092
P577
2013-05-27T00:00:00Z